Pfizer patent blow after UK ruling on €4.4bn pain drug

Pfizer has lost the final round in a long-running patent battle in the UK after the country’s highest court ruled against it in a case involving its €4.4bn-a-year pain drug Lyrica.

Pfizer patent blow after UK ruling on €4.4bn pain drug

By Ben Hirschler

Pfizer has lost the final round in a long-running patent battle in the UK after the country’s highest court ruled against it in a case involving its €4.4bn-a-year pain drug Lyrica.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited